Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone vs losartan in mild to moderate primary hypertension
CTR20131433Phase 3Active
- Sponsor
- Zhejiang Xianju Pharmaceutical Co., Ltd.
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eplerenone in essential hypertension, sponsored by Zhejiang Xianju Pharmaceutical Co., Ltd.. Started Jan 2015; status: active.
02
Drugs
eplerenone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20131433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131433.